Crossmark

Histidine triad nucleotide-binding protein 2 attenuates metabolic dysfunction-associated steatotic liver disease through NAD+-dependent sirtuin-3 activation

Crossref DOI link: https://doi.org/10.1038/s12276-025-01445-w

Published Online: 2025-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Qinqiu

Guo, Yanjun

Chen, Shenghui

Liu, Zhening

Wang, Xinyu

Huang, Hangkai

Shen, Qi-en

Yang, Ling

Li, Meng

Li, Youming

Yu, Chaohui https://orcid.org/0000-0003-4842-3646
Xu, Chengfu https://orcid.org/0000-0002-6172-1253
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82070585)

National Natural Science Foundation of China (81770573)

National Natural Science Foundation of China (81722009)

National Natural Science Foundation of China (82370574)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 7 July 2024

Revised: 8 February 2025

Accepted: 18 February 2025

First Online: 1 May 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below